4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-23-024158
EVP Research & Development sold 2,500 shares at $34.86 ($87,150)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Malik Fady Ibraham EVP Research & Development | 2023-09-14 | Sale 10b5-1 | −2,500 | $34.86 | $87,150 | 155,664 | D: show line 1 in the form |
| Open-market sales · 2,500 sh · avg $34.86 · $87,150 | |||||||
Loading xslF345X05/form4.xml…